Medicare Part D coverage · erythromycin · RxCUI 310154
erythromycin 250 MG Delayed Release Oral Capsule
Per the CMS 2026 Part D formulary file, erythromycin 250 MG Delayed Release Oral Capsule is covered by 4,281 Medicare Part D plans (84.7% of enrollable products), averaging Tier 3.3, with prior authorization required on 0% of covering formularies.
- 84.7%
- Plan coverage
- 4,281
- Plans covering
- T3.3
- Avg tier
- 0%
- Prior auth required
What the CMS Formulary Data Shows for erythromycin 250 MG Delayed Release Oral Capsule
Per the CMS 2026 Part D formulary file, erythromycin 250 MG Delayed Release Oral Capsule (RxNorm concept RXCUI 310154, generic name erythromycin) appears on 192 distinct formulary files spanning 4,281 Medicare Part D plan offerings - 84.7% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 3.3.
Real-world access to erythromycin 250 MG Delayed Release Oral Capsule depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 1,861 Part D beneficiaries filled erythromycin 250 MG Delayed Release Oral Capsule in 2023, with total plan-and-beneficiary spending of $4,499,767 and an average per-beneficiary annual cost of $2,417.93. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry erythromycin 250 MG Delayed Release Oral Capsule today.
Coverage Details
- Formularies covering
- 192
- Plans covering
- 4,281
- Coverage rate
- 84.7%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 1,861
- Total spending
- $4,499,767
- Avg per beneficiary
- $2,417.93
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering erythromycin 250 MG Delayed Release Oral Capsule
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Sentara Community Complete Select (HMO D-SNP) | Sentara Health Plans | T1 | No | $0 | VA |
| Sentara Community Complete (HMO D-SNP) | Sentara Health Plans | T1 | No | $0 | VA |
| Florida Complete Care-Duals VIP (HMO-POS D-SNP) | Hpmp OF Florida, Inc. | T1 | No | $0 | FL |
| ElderServe MAP (HMO D-SNP) | Elderserve Health, Inc. | T1 | No | $0 | NY |
| Cooperative Advantage (HMO D-SNP) | Group Health Cooperative OF EAU Claire | T1 | No | $0 | WI |
| Longevity Health Plan (PPO I-SNP) | Longevity Health Plan OF NEW Jersey Insurance Comp | T1 | No | $0 | NJ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | No | $0 | AZ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | No | $0 | AZ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | No | $0 | AZ |
| Elderplan Plus Long-Term Care (HMO-POS D-SNP) | Elderplan, Inc. | T1 | No | $0 | NY |
| Health Choice Pathway (HMO D-SNP) | Health Choice Arizona, Inc. | T1 | No | $0 | AZ |
| Healthfirst CompleteCare (HMO D-SNP) | Healthfirst Health Plan, Inc. | T1 | No | $0 | NY |
| IMCare Classic (HMO D-SNP) | Itasca Medical Care | T1 | No | $0 | MN |
| Johns Hopkins Advantage MD D-SNP (HMO D-SNP) | Hopkins Health Advantage, Inc. | T1 | No | $0 | MD |
| MetroPlus UltraCare (HMO D-SNP) | Metroplus Health Plan, Inc. | T1 | No | $0 | NY |
| Upper Peninsula Health Plan MI Coordinated Health (HMO D-SNP) | Upper Peninsula Health Plan, LLC | T1 | No | $0 | MI |
| CareSource Dual Advantage (HMO D-SNP) | Caresource Georgia Co. | T1 | No | $0 | GA |
| Senior Whole Health SCO (HMO D-SNP) | Senior Whole Health, LLC | T1 | No | $0 | MA |
| Senior Whole Health SCO NHC (HMO D-SNP) | Senior Whole Health, LLC | T1 | No | $0 | MA |
| Molina One Care (HMO D-SNP) | Senior Whole Health, LLC | T1 | No | $0 | MA |
Show the next 30 plans
| HAP CareSource MI Coordinated Health (HMO D-SNP) | HAP Caresource | T1 | No | $0 | MI |
| Gold Coast Health Plan Total Care Advantage (HMO D-SNP) | Ventura County Medi-Cal Managed Care Commission | T1 | No | $0 | CA |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | Health Care Service Corporation | T1 | No | $0 | NM |
| Blue Cross MA Dual Care Plus Preferred (PPO D-SNP) | Health Care Service Corporation | T1 | No | $0 | NM |
| Horizon NJ TotalCare (HMO D-SNP) | Horizon Healthcare OF NEW Jersey, Inc. | T1 | No | $0 | NJ |
| SecureBlue (HMO D-SNP) | HMO Minnesota | T1 | No | $0 | MN |
| NaviCare (HMO D-SNP) | Fallon Community Health Plan | T1 | No | $0 | MA |
| Hamaspik Medicare Choice (HMO D-SNP) | Hamaspik, Inc. | T1 | No | $0 | NY |
| CCA One Care (HMO D-SNP) | Commonwealth Care Alliance, Inc. | T1 | No | $0 | MA |
| CCA Senior Care Options (HMO D-SNP) | Commonwealth Care Alliance, Inc. | T1 | No | $0 | MA |
| Community Care's Partnership Program (HMO D-SNP) | Community Care Health Plan, Inc. | T1 | No | $0 | WI |
| Mass General Brigham SCO (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | No | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | No | $0 | MA |
| Tufts Health One Care (HMO D-SNP) | Tufts Health Public Plans, Inc. | T1 | No | $0 | MA |
| Tufts Health One Care CW (HMO D-SNP) | Tufts Health Public Plans, Inc. | T1 | No | $0 | MA |
| Tufts Health Plan Senior Care Options (HMO D-SNP) | Tufts Associated Health Maintenance Organization | T1 | No | $0 | MA |
| Tufts Health Plan Senior Care Options CW (HMO D-SNP) | Tufts Associated Health Maintenance Organization | T1 | No | $0 | MA |
| Florida Complete Care (HMO I-SNP) | Hpmp OF Florida, Inc. | T1 | No | $4.80 | FL |
| Florida Complete Care- In The Community (HMO-POS I-SNP) | Hpmp OF Florida, Inc. | T1 | No | $4.80 | FL |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF Florida, Inc. | T1 | No | $4.80 | FL |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | Hcsc Insurance Services Company | T1 | No | $4.80 | TX |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | GHS Insurance Company | T1 | No | $5.00 | OK |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF Michigan, Inc. | T1 | No | $8.80 | MI |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF Illinois, Inc. | T1 | No | $15.20 | IL |
| WellSense Added Value (HMO) | Boston Medical Center Health Plan, Inc. | T1 | No | $21.70 | NH |
| Elderplan For Medicaid Beneficiaries (HMO-POS D-SNP) | Elderplan, Inc. | T1 | No | $22.70 | NY |
| VIVA Medicare Extra Value (HMO D-SNP) | Viva Health, Inc. | T1 | No | $27.70 | AL |
| VIVA Medicare Extra Care (HMO D-SNP) | Viva Health, Inc. | T1 | No | $27.70 | AL |
| Hamaspik Medicare Select (HMO D-SNP) | Hamaspik, Inc. | T1 | No | $34.50 | NY |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF Colorado, Inc. | T1 | No | $35.20 | CO |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is erythromycin 250 MG Delayed Release Oral Capsule covered by Medicare Part D?
Yes, erythromycin 250 MG Delayed Release Oral Capsule is covered by 4,281 Medicare Part D plans (84.7% of all Part D formularies).
What tier is erythromycin 250 MG Delayed Release Oral Capsule on Medicare Part D plans?
erythromycin 250 MG Delayed Release Oral Capsule averages Tier 3.3 across Part D plans, ranging from Tier 1 to Tier 4.
Does erythromycin 250 MG Delayed Release Oral Capsule require prior authorization?
0% of Part D formularies require prior authorization for erythromycin 250 MG Delayed Release Oral Capsule. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on erythromycin 250 MG Delayed Release Oral Capsule?
In 2023, total Medicare Part D spending on erythromycin 250 MG Delayed Release Oral Capsule was $4,499,767, covering 1,861 beneficiaries. The average spend per beneficiary was $2,417.93.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- abacavir 60 MG / dolutegravir 5 MG / lamivudine 30 MG Tablet for Oral Suspension [Triumeq] T3.3
- natamycin 50 MG/ML Ophthalmic Suspension [Natacyn] T3.3
- rifapentine 150 MG Oral Tablet [Priftin] T3.3
- alanine 20.7 MG/ML / arginine 11.5 MG/ML / glycine 10.3 MG/ML / histidine 4.8 MG/ML / isoleucine 6 MG/ML / leucine 7.3 MG/ML / lysine 5.8 MG/ML / methionine 4 MG/ML / phenylalanine 5.6 MG/ML / proline 6.8 MG/ML / serine 5 MG/ML / threonine 4.2 MG/ML / tryptophan 1.8 MG/ML / tyrosine 0.4 MG/ML / valine 5.8 MG/ML Injectable Solution [Travasol 10] T3.3
- doxycycline anhydrous 40 MG Delayed Release Oral Capsule T3.3
- etravirine 25 MG Oral Tablet [Intelence] T3.3